Slone Partners Find New CMO for Sera Prognostics
October 16, 2018 – Executive search firm Slone Partners has recruited Garrett K. Lam as the new chief medical officer for Sera Prognostics in Salt Lake City, UT.
“Slone Partners worked closely with Sera as we conducted this important search,” said Greg Critchfield, chairman and chief executive officer of Sera. “They paved the way for great conversations between candidates and the entire Sera leadership team. Slone Partners deserves high praise for informative, communicative and helpful support as we spoke with a number of excellent candidates and completed our search with Dr. Lam joining as our new chief medical officer.”
Leslie Loveless, CEO of Slone Partners, said the placement was a positive for all involved, including patients and their families. “As Sera Prognostics continues its singular global quest of improving the health and lives of women and infants, assembling world-class maternal fetal medicine leaders like Dr. Lam is paramount for both commercial success and making new scientific healthcare discoveries,” she said. “We are absolutely delighted to have partnered with Sera on this important leadership role that positively and nobly impacts expectant mothers.”
Prior to becoming professor and chairman of obstetrics and gynecology at the University of Tennessee College of Medicine-Chattanooga, Dr. Lam received his medical degree from the University of Rochester and completed his obstetrics and gynecology residency at Good Samaritan Regional Medical Center in Phoenix., AZ. He received his fellowship training in maternal fetal medicine at the University of North Carolina, Chapel Hill. Dr. Lam has authored multiple book chapters and contributed to numerous peer-reviewed articles in leading journals based on investigations of various clinical subjects such as preeclampsia, preterm labor, postpartum hemorrhage, fetal anomalies, and genomic medicine.
At Sera, Dr. Lam will oversee clinical operations personnel and collaborate with research teams across the world.
Sera Prognostics is a global leader in high value women’s health diagnostics, delivering pivotal information to physicians to improve health and improve the economics of healthcare delivery for pregnant women. The organization is developing innovative diagnostic tests focused on the early prediction of preterm birth risk and other complications of pregnancy.
Slone Partners Lands Chief Medical Officer for Clinical Genomics
Dr. Dugan is a well-known biotechnology leader with extensive clinical experience in both commercial and academic settings. Previously, he served as president and chief executive officer of MCDXI Medical Diagnostics International.
Slone Partners is a nationally recognized senior-level recruitment provider that specializes in delivering executive, management and leadership talent for the diagnostic, biopharmaceutical, healthcare information technology and laboratory testing industries. It has offices in Boston, New York, Washington, D.C. and San Francisco. Recently, Slone Partners was named to Hunt Scanlon Media’s “Top 50 Healthcare & Life Sciences Search Firms” rankings.
Chief Medical Officers
According to recruiters, the role of the chief medical officer has evolved in recent years, and organizations are looking for leaders with broader skill-sets. “Today’s CMO needs to have professional experience gathered from different players in the drug development industry, since he or she needs to understand the objectives of the key players in the field,” said Marc Salzberg, CEO of Airway Therapeutics, in reference to academia / clinical practice, the pharma industry, regulatory authorities and third party vendors such as contract research organizations in order to successfully cooperate with those partners.”
Over the past year several healthcare organizations have turned to executive search firms to find new CMOs. Here is a sampling from the Hunt Scanlon Media archives:
CalvertHealth, a Prince Frederick, MD-based healthcare system, has enlisted Buffkin / Baker to find its next chief medical officer. The ideal candidate will be a progressive physician leader that can drive clinical excellence, best practices and quality initiatives in order to improve patient outcomes across the system.
Chicago-based executive recruitment firm Carrington & Carrington has been selected by Planned Parenthood Federation of America to find its next chief medical officer. “The CMO serves as a visionary, strategic thinker, and national thought leader on clinical issues, both in the Planned Parenthood setting and the field of women’s health broadly.”
Coulter Partners placed David Michelson as the chief medical officer of Proclara Biosciences in Cambridge, MA. “David is a seasoned leader, with deep research, clinical and regulatory expertise, including significant experience in neurology and I thank the Coulter Partners team for their outstanding work in achieving this high caliber appointment.”
Contributed by Scott A. Scanlon, Editor-in-Chief; Dale M. Zupsansky, Managing Editor; Stephen Sawicki, Managing Editor; and Andrew W. Mitchell, Managing Editor – Hunt Scanlon Media
